Condensed Consolidated Statement of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Revenue
Patient service revenue, net	$ 1,514,376	$ 1,336,940
Consulting and event revenue	87,655
Product revenue	182,663
Total revenue	1,784,694	1,336,940
Operating Expenses and Costs
Practice salaries and benefits	663,937	765,121
Other practice operating expenses	730,784	563,691
Medicare shared savings expenses	211,507
Cost of product revenue	168,596
Selling, general and administrative expenses	1,366,137	510,976
Depreciation and amortization	211,658	24,786
Total Operating Expenses and Costs	3,352,619	1,864,574
Loss from operations	(1,567,925)	(527,634)
Other Income (Expenses)
Loss on extinguishment of debt	(5,589,994)	(467,937)
Change in fair value of debt	(19,246)	35,965
Amortization of original issue and debt discounts on notes payable and convertible notes		(292,163)
Change in fair value of derivative financial instruments		740,355
Change in fair value of contingent acquisition consideration	(635,700)	(6,621)
Interest expense	(10,588)	(62,181)
Total other expenses	(6,255,528)	(52,582)
Net loss before provision for income taxes	(7,823,453)	(580,216)
Provision for income taxes
Net loss	(7,823,453)	(580,216)
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	(88,393)
Net loss to common stockholders	$ (7,911,846)	$ (580,216)
Basic (in Dollars per share)	$ (0.04)	$ (0.01)
Fully diluted (in Dollars per share)	$ (0.04)	$ (0.01)
Basic (in Shares)	213,279,052	114,601,960
Fully diluted (in Shares)	213,279,052	114,601,960